We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
TotalEnergies
TTE
$193B
| $56K | ﹤0.01% |
972
+348
| +56% | +$21.1K |
|
852
Euronet Worldwide
EEFT
$3.02B
| $55.8K | ﹤0.01% |
475
| – | – |
|
853
Expeditors International
EXPD
$22.9B
| $55.7K | ﹤0.01% |
460
| – | – |
|
854
Autoliv
ALV
$8.6B
| $55.5K | ﹤0.01% |
653
| – | – |
|
855
Simpson Manufacturing
SSD
$7.98B
| $55.4K | ﹤0.01% |
400
| – | – |
|
856
Cousins Properties
CUZ
$5.29B
| $55.3K | ﹤0.01% |
2,425
| – | – |
|
857
Conagra Brands
CAG
$7.07B
| $55.1K | ﹤0.01% |
1,634
| – | – |
|
|
TGNA
858
DELISTED
TEGNA Inc
TGNA
| $54.7K | ﹤0.01% |
3,366
| – | – |
|
|
CNR
859
Core Natural Resources Inc
CNR
$4.19B
| $54.5K | ﹤0.01% |
803
| – | – |
|
860
Interparfums
IPAR
$3.92B
| $54.1K | ﹤0.01% |
400
-1,400
| -78% | -$196K |
|
|
ORIO
861
Orion Digital Corp
ORIO
$15.4M
| $54K | ﹤0.01% |
26,400
-3,333
| -11% | -$7.13K |
|
862
BioNTech
BNTX
$22.6B
| $54K | ﹤0.01% |
500
| – | – |
|
863
Vanguard Mid-Cap Value ETF
VOE
$23.7B
| $53.8K | ﹤0.01% |
388
-1,224
| -76% | -$163K |
|
864
Fair Isaac
FICO
$28.7B
| $53.4K | ﹤0.01% |
66
+50
| +313% | +$37.5K |
|
865
iShares MSCI Intl Quality Factor ETF
IQLT
$13.6B
| $53.4K | ﹤0.01% |
+1,500
| New | +$53.5K |
|
866
Starwood Property Trust
STWD
$6.12B
| $53.4K | ﹤0.01% |
2,750
+1,600
| +139% | +$28.4K |
|
867
CalciMedica
CALC
$12M
| $53K | ﹤0.01% |
+13,226
| New | +$57.8K |
|
868
iShare MSCI Eurozone ETF
EZU
$9.41B
| $52.7K | ﹤0.01% |
1,150
-90
| -7% | -$4.1K |
|
869
Intuit
INTU
$81.1B
| $52.7K | ﹤0.01% |
115
-13
| -10% | -$5.69K |
|
870
Highwoods Properties
HIW
$3.71B
| $52.6K | ﹤0.01% |
2,200
| – | – |
|
871
Johnson Outdoors
JOUT
$482M
| $52.2K | ﹤0.01% |
850
| – | – |
|
872
CenterPoint Energy
CNP
$29.1B
| $51.4K | ﹤0.01% |
1,762
| – | – |
|
873
Marvell Technology
MRVL
$174B
| $50.4K | ﹤0.01% |
843
+143
| +20% | +$6.95K |
|
874
Brixmor Property Group
BRX
$9.95B
| $50.4K | ﹤0.01% |
2,290
| – | – |
|
875
Dell
DELL
$283B
| $50.1K | ﹤0.01% |
926
| – | – |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.